MIGLIOLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 1.450
EU - Europa 1.172
AS - Asia 294
AF - Africa 78
SA - Sud America 6
OC - Oceania 1
Totale 3.001
Nazione #
US - Stati Uniti d'America 1.446
SE - Svezia 284
GB - Regno Unito 245
IT - Italia 174
DE - Germania 147
SG - Singapore 93
CN - Cina 87
IE - Irlanda 86
UA - Ucraina 57
BG - Bulgaria 55
IN - India 46
FR - Francia 39
CI - Costa d'Avorio 33
CH - Svizzera 29
TG - Togo 26
VN - Vietnam 25
JO - Giordania 24
RU - Federazione Russa 17
FI - Finlandia 14
ZA - Sudafrica 14
IR - Iran 11
EE - Estonia 9
JP - Giappone 7
BR - Brasile 4
CA - Canada 4
RO - Romania 4
SC - Seychelles 4
BE - Belgio 3
ES - Italia 3
NL - Olanda 3
AT - Austria 1
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
Totale 3.001
Città #
Chandler 287
Southend 203
Ashburn 105
Fairfield 104
Princeton 97
Dublin 86
Singapore 76
Ann Arbor 51
Sofia 51
Wilmington 49
Woodbridge 46
Berlin 42
Cambridge 42
Houston 42
Jacksonville 41
Seattle 37
Abidjan 33
Bern 28
Lomé 26
Amman 24
Bologna 24
Dong Ket 24
Nanjing 20
Milan 18
Padova 16
Westminster 16
Turin 15
New York 14
Helsinki 13
Santa Clara 13
San Diego 10
Beijing 9
Los Angeles 8
Olalla 8
Boardman 7
Mountain View 7
Mülheim 7
Nanchang 7
Tokyo 6
Guangzhou 5
Jinan 5
Medford 5
Saint Petersburg 5
Shenyang 5
Boydton 4
Bremen 4
Changsha 4
Frankfurt am Main 4
Haikou 4
Hebei 4
London 4
Mahé 4
São Paulo 4
Zhengzhou 4
Brussels 3
Campobasso 3
Cesenatico 3
Chiampo 3
Dearborn 3
Leawood 3
Monticelli 3
Nuremberg 3
Paris 3
Perugia 3
Redmond 3
Redwood City 3
Reggio Emilia 3
Taizhou 3
Verona 3
Washington 3
Zanjan 3
Amsterdam 2
Andover 2
Boves 2
Bronte 2
Brugherio 2
Bühl 2
Casalgrande 2
Costa Mesa 2
Hamburg 2
Jiaxing 2
Madrid 2
Naples 2
Napoli 2
Ningbo 2
Norwalk 2
Nottingham 2
Pellezzano 2
Piacenza 2
Prato 2
Prescot 2
Pune 2
Rome 2
Sant'Ilario d'Enza 2
Taiyuan 2
Toronto 2
Augusta 1
Baia Mare 1
Bochum 1
Buffalo 1
Totale 1.882
Nome #
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 160
Erosions or not in GORD? The potential role of oesophageal cell proliferation 150
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 139
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 128
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 127
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 124
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 121
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 109
Erosions or not in GERD? The potential role of esophageal cell kinetics 102
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 98
Three-year experience in clinical intestinal transplantation 97
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 96
Diagnosi dell’infezione da Helicobacter pylori 95
Peptic ulcer and Helicobacter pylori. 85
Diagnosi non invasiva e terapia per Helicobacter Pylori 84
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 83
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 70
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 70
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 61
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 48
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 45
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 45
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 41
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 40
Macrophage subpopulations in pouchitis 40
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 38
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 36
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 35
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 35
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 35
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 34
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 34
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis 34
Role of rectal formulations: Enemas 33
Bronchopulmonary involvement in ulcerative colitis 33
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 32
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 32
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 31
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis 31
Interleukin 1 in ulcerative colitis 30
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 29
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 29
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 23
Pentasa in maintenance treatment of ulcerative colitis 23
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 21
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 19
Rifaximin suspension for the eradication of helicobacter pylori 12
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 11
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 10
Lactose Malabsorption in Adult Patients with Crohn's Disease 10
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 8
High eradication rates of Helicobacter pylori with a new sequential treatment 7
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 7
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 7
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 7
Helicobacter pylori and diminished growth in children: Is it simply a marker of deprivation? 7
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 7
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 6
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 6
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 6
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 6
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 6
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 5
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 5
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 5
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 5
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 5
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 5
Source of Helicobacter pylori Infection 4
Biliary surgery without the surgeon! 4
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 4
Symptoms and Helicobacter pylori: Any link [6] 4
High eradication rates of Helicobacter pylori with a new sequential treatment 4
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 4
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 4
Susceptibility of Helicobacter pylori to Metronidazole 4
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 4
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 4
Review article: Diagnosis of Helicobacter pylori infection 3
Helicobacter pylori and other spiral organisms in gastroduodenal disease 3
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 3
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 3
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 3
Treatment of symptom-free Helicobacter pylori-positive subjects 3
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia 3
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 2
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 2
Routes of trasmission of Helicobacter pylori infection 2
Lipid peroxidation and antioxidant status in adults receiving lipid- based home parenteral nutrition 2
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 1
Therapeutic news on Helicobacter pylori from Budapest and Wien 1
Screening for Helicobacter pylori 1
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 1
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients [17] 1
Helicobacter pylori and other spiral organisms in gastroduodenal disease 1
Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: A case-control study in italy 1
Helicobacter pylori: Diseases, tests and treatment 1
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 1
Therapeutic news on Helicobacter pylori from Budapest and Wien 1
Usefulness of serology in preendoscopic screening 1
Totale 3.138
Categoria #
all - tutte 12.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020378 0 8 8 35 38 47 47 68 48 22 17 40
2020/2021220 51 19 7 12 10 17 2 12 14 15 14 47
2021/2022687 19 12 30 34 36 14 4 25 125 71 207 110
2022/20231.024 109 172 88 84 69 80 28 69 182 21 50 72
2023/2024444 96 66 30 60 32 83 12 23 3 23 7 9
2024/2025126 59 67 0 0 0 0 0 0 0 0 0 0
Totale 3.147